Effects of EGFR-TKIs combined with intracranial radiotherapy in EGFR-mutant non-small cell lung cancer patients with brain metastases: a retrospective multi-institutional analysis

被引：0

作者：

Mingfeng He ^{[1
]}

Xue Wu ^{[1
]}

Li Li ^{[2
]}

Guangming Yi ^{[1
]}

Yitian Wang ^{[4
]}

Hengqiu He ^{[1
]}

Ying Ye ^{[1
]}

Ruiqin Zhou ^{[2
]}

Zaicheng Xu ^{[3
]}

Zhenzhou Yang ^{[1
]}

机构：

[1] The Second Affiliated Hospital of Chongqing Medical University,Department of Oncology

[2] The Second Affiliated Hospital of Chongqing Medical University,Department of Cardiothoracic Surgery

[3] The First Affiliated Hospital of Chongqing Medical University,Department of Cardiothoracic Surgery

[4] The Third Hospital of Mianyang (Sichuan Mental Health Center),Department of Oncology

来源：

Radiation Oncology | / 20卷 / 1期

关键词：

Non-small-cell lung cancer; Brain metastases; EGFR-TKI; Intracranial radiotherapy; Overall survival;

D O I：

10.1186/s13014-024-02578-4

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[31] The prognostic role of EGFR-TKIs for patients with advanced non-small cell lung cancer
Dan Zhao
Xuejing Chen
Na Qin
Dan Su
Lijuan Zhou
Quan Zhang
Xi Li
Xinyong Zhang
Mulan Jin
Jinghui Wang
Scientific Reports, 7
[32] Combination therapy of brain radiotherapy and EGFR-TKIs is more effective than TKIs alone for EGFR-mutant lung adenocarcinoma patients with asymptomatic brain metastasis
Yanxin Chen
Jianping Wei
Jing Cai
Anwen Liu
BMC Cancer, 19
[33] Combination therapy of brain radiotherapy and EGFR-TKIs is more effective than TKIs alone for EGFR-mutant lung adenocarcinoma patients with asymptomatic brain metastasis
Chen, Yanxin
Wei, Jianping
Cai, Jing
Liu, Anwen
BMC CANCER, 2019, 19 (01)
[34] Multibiomarker analysis homing in on EGFR-TKIs therapy in non-small cell lung cancer
Bai, H.
An, T.
Zhuo, M.
Zhao, J.
Wu, M.
Duan, J.
Yang, L.
Wang, Z.
Wang, J.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[35] The past, present, and future management of brain metastases in EGFR-mutant non-small cell lung cancer
Sperduto, Paul W.
Lou, Emil
NEURO-ONCOLOGY, 2021, 23 (06) : 867 - 868
[36] Lysine Deprivation Induces AKT-AADAT Signaling and Overcomes EGFR-TKIs Resistance in EGFR-Mutant Non-Small Cell Lung Cancer Cells
Hsu, Chia-Chi
Yang, Albert Ying-Po
Chen, Jui-Yi
Tsai, Hsin-Hui
Lin, Shu-Heng
Tai, Pei-Chen
Huang, Ming-Hung
Hsu, Wei-Hsun
Lin, Anya Maan-Yuh
Yang, James Chih-Hsin
CANCERS, 2021, 13 (02) : 1 - 17
[37] Concurrent use of metformin enhances the efficacy of EGFR-TKIs in patients with advanced EGFR-mutant non-small cell lung cancer-an option for overcoming EGFR-TKI resistance
Han, Ruoshuang
Jia, Yijun
Li, Xuefei
Zhao, Chao
Zhao, Sha
Liu, Sangtian
Liu, Yiwei
Chen, Donglai
Zhang, Qian
Liu, Xiaozhen
Shi, Jinpeng
Li, Jiayu
Zhou, Caicun
TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (03) : 1277 - 1291
[38] AFATINIB IN EGFR MUTANT NON-SMALL-CELL LUNG CANCER PATIENTS WITH ACQUIRED RESISTANCE TO REVERSIBLE EGFR-TKIS
Cappuzzo, Federico
Tiseo, Marcello
Chiari, Rita
Landi, Lorenza
Ricciardi, Serena
Rossi, Elisa
Galetta, Domenico
Novello, Silvia
Milella, Michele
D'Incecco, Armida
Haspinger, Eva Regina
Cortinovis, Diego
Santo, Antonio
Banna, Giuseppe
Facchi-Netti, Francesco
Levra, Matteo Giaj
Vari, Sabrina
Crino, Lucio
De Marinis, Filippo
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S610 - S610
[39] Rationale and value of consolidative cranial local therapy in EGFR-mutant non-small cell lung cancer patients with baseline brain metastasis treated with first-line EGFR-TKIs
Zeng, Ya
Su, Xi
Zhao, Yang
Zhou, Yue
Guo, Tiantian
Chu, Xiao
Chu, Li
Yang, Xi
Ni, Jianjiao
Zhu, Zhengfei
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
[40] Chemotherapy plus EGFR-TKIs versus EGFR-TKIs Alone in Non-small Cell Lung Cancer with EGFR-Activating Mutations: A Meta-analysis
Han, G.
Peng, M.
Weng, Y.
Zou, J.
Song, Q.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E458 - E458

← 1 2 3 4 5 →